Tibra Equities Europe’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-11,100
Closed -$521K 167
2020
Q3
$521K Buy
+11,100
New +$570K 0.11% 77
2019
Q3
Sell
-13,900
Closed -$655K 239
2019
Q2
$655K Buy
+13,900
New +$641K 0.05% 174
2019
Q1
Sell
-24,000
Closed -$1.07M 384
2018
Q4
$1.07M Buy
+24,000
New +$1.25M 0.18% 90
2018
Q3
Sell
-25,614
Closed -$1.25M 204
2018
Q2
$1.25M Buy
+25,614
New +$1.45M 0.19% 91
2018
Q1
Sell
-14,755
Closed -$904K 201
2017
Q4
$904K Buy
+14,755
New +$912K 0.39% 58

Other funds holding CAH

Tibra Equities Europe's CAH Position: Q4 2020 in Review

Tibra Equities Europe sold out of Cardinal Health (CAH) in Q4 2020, closing a stake of 11,100 shares — an estimated $521K sold.

Tibra Equities Europe first reported a position in CAH in Q4 2017 and held it in 5 quarters. The position peaked at $1.25M in Q2 2018. 779 funds tracked by Wall St. Rank hold CAH as of Q4 2020.

  • Tibra Equities Europe reported no remaining Cardinal Health position as of Q4 2020 after selling out during the quarter.
  • Tibra Equities Europe sold 11,100 Cardinal Health shares in Q4 2020, an estimated $521K.
  • Tibra Equities Europe first reported a position in Cardinal Health in Q4 2017 and held it in 5 quarters.
  • Tibra Equities Europe's Cardinal Health position peaked at $1.25M in Q2 2018.
  • 779 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2020.

Based on Tibra Equities Europe's 13F filing for Q4 2020, filed 12 Feb 2021.